NEW YORK, Nov. 15 — Genomics firm Lynx Therapeutics and the University of California at Davis will partner to study gene expression in Arabidopsis, a project that will generate the first publicly available genome-wide data set in a plant, Lynx said on Thursday.
Under the terms of the agreement, Lynx will be paid to analyze genes in different Arabidopsis tissues, which will be provided by the Davis team. Data will be made available on the Internet.
Blake Meyers, who will lead the Davuis effort, said that he believed Lynx' sequencing technology will generate useful new quantitative gene-expression data that has not previously been accessible with microarray work. The project is intended to be a proof-of-concept study to see how Lynx' Massively Parallel Signature Sequencing system works with plant gene expression.
The research will be funded by a $1 million, 2-year grant from the National Science Foundation under its National Plant Genome Research Program. The NPGRP has boosted its grant outlays for plant research for the coming year and has awarded a total of $71 million in awards this year.